Performance of the Travoprost Intraocular Implant
Trial details
- Registry ID
- NCT06582732
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as iDose TR
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Performance of the Travoprost Intraocular ImplantNCT06582732 | Glaukos Corporation | Phase 2 | Completed | 2023-11-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |